Latest Asx Price Query News

Amplia Therapeutics has told ASX it is unaware of any undisclosed information that explains a sharp fall in its share price and a surge in trading volume. The response followed an ASX price query issued after the stock dropped from $0.100 to $0.079 on 16 October.

Cleanaway has told ASX it knows of no undisclosed information behind a sharp intraday share-price fall. The company said it will provide another update on EQT’s proposed takeover before trading begins on 19 October.

SKS Technologies has denied knowledge of undisclosed information after ASX queried a sharp share price reversal and significant trading volume. The company said its projects, work in hand and data centre opportunity pipeline remained unchanged.

Image Resources says it knows of no undisclosed information that could explain its share price more than doubling between 9 and 13 October. The response follows an ASX price query prompted by the move and a surge in trading volume.

Rubicon Water has told ASX that the selection of a joint venture bid containing about A$12 million of its technology was price-sensitive information. The company said it only learned of the decision when it appeared on Morocco’s procurement portal, then lodged its announcement after an overnight review and a four-second technical delay.

Suncorp Group has rejected speculation that it is in takeover discussions with Tokio Marine after its shares climbed from $19.05 to $20.18 and trading volumes increased. The insurer told the ASX it had received no takeover offer and knew of no undisclosed information explaining the move.

Cauldron Energy has told the ASX it knows of no undisclosed information behind a sharp fall in its share price and a surge in trading activity. The company has pointed instead to a possible Betashares Global Uranium ETF rebalance, while stressing that explanation remains unconfirmed.

BOA Resources says it is unaware of undisclosed information behind a sharp increase in trading, despite further Ricci Lee assay results remaining pending through October. The company attributed the move to investor reaction to its recent high-grade copper announcement.

Micro-X has told ASX it is unaware of any undisclosed information explaining the sharp move in its shares, which rose from $0.030 to $0.045 during 23 September trading. The company pointed to elevated volumes, earlier institutional selling and chairman Patrick O’Brien’s purchase of 1.36 million shares.

Native Mineral Resources has told ASX it is unaware of any undisclosed information behind recent trading in its shares. The company pointed to record August gold output, a Citigold joint venture, Blackjack drilling results and stronger gold prices instead.

Mount Ridley Mines has told ASX it holds no unreleased exploration results that explain its share price rise, while confirming three testwork programs remain in progress. The company also disclosed that an institutional investor had approached it about participating in its current capital raising.

Actinogen Medical (ASX:ACW) has clarified that no undisclosed information explains recent unusual trading in its shares, pointing instead to recent underwriting of options and published updates. The biotech also reaffirmed compliance with ASX rules and provided a detailed update on its lead Alzheimer’s drug Xanamem and ongoing clinical trials.